Status and Problems of Adverse Event Reporting Systems in Korean Hospitals [PDF]
Healthcare Informatics Research, 2010 ObjectivesThis study identifies the current status and problems of adverse event reporting system in Korean hospitals. The data obtained from this study will be used to raise international awareness and enable collaborative researches on patient safety ...
Jeongeun Kim +3 more
doaj +9 more sources
Adverse event reporting systems and safer healthcare [PDF]
Quality and Safety in Health Care, 2009 At the heart of improvement and safety in healthcare is the now-familiar tenet that was espoused decades ago by Demming and paraphrased by Berwick.1 Need we repeat it again? Every defect should lead to improvement processes that make care safer. It is time to deliver on the promise of reporting systems in patient safety.
James B Battles, David Stevens
openalex +4 more sources
Military Healthcare Providers Reporting of Adverse Events Following Immunizations to the Vaccine Adverse Event Reporting System [PDF]
Military Medicine, 2014 We studied military health care provider (HCP) practices regarding reporting of adverse events following immunization (AEFI).A convenience sample of HCP was surveyed to assess familiarity with Vaccine Adverse Event Reporting System (VAERS), AEFI they were likely to report, methods used and preferred for reporting, and perceived barriers to reporting ...
Rongxia Li +7 more
openalex +3 more sources
Assessing taxane-associated adverse events using the FDA adverse event reporting system database
Chinese Medical Journal, 2021 . Background:. Taxanes are an essential class of antineoplastic agents used to treat various cancers and are a fundamental cause of hypersensitivity reactions. In addition, other adverse events, such as bone marrow toxicity and peripheral neuropathy, can
Dong-Hui Lao +4 more
doaj +3 more sources
Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
Frontiers in PharmacologyBackgroundTeriparatide is approved for osteoporosis. Post-marketing surveillance is critical given its widespread use.ObjectiveTo investigate adverse events (AEs) associated with teriparatide using the FAERS database, compare association strengths for ...
Ming-Tao Wen +11 more
doaj +3 more sources
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system. [PDF]
PLoS ONE, 2017 Doxorubicin (DOX) is an anthracycline widely used for the treatment of solid and hematological tumors. The aim of this study was to assess the adverse event profiles of conventional DOX and liposomal DOX. This is the first study to evaluate the effect of
Akiho Fukuda +12 more
doaj +3 more sources
Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database [PDF]
Journal of Managed Care & Specialty Pharmacy, 2018 Data on adverse drug events (ADEs) observed at the population level provide important evidence regarding the safety of a pharmaceutical product in real-world settings. Recent patterns in serious and fatal ADE reporting have not been documented.To assess recent patterns in serious and fatal ADE reports in the United States.We conducted a retrospective ...
Kalyani Sonawane +2 more
openalex +4 more sources
Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system [PDF]
BMC Pharmacology and Toxicology, 2020 Background To describe and analyze the patterns of adverse events associated with dipeptidyl peptidase-4 inhibitors (DPP-4is) (sitagliptin, saxagliptin, linagliptin, vildagliptin, and alogliptin) from the FDA Adverse Event Reporting System (FAERS) and to
Jing Huang +3 more
doaj +2 more sources
Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis [PDF]
, 2020 Background: Adverse drug reactions (ADRs) can occur any time someone uses a medication. ADRs are systematically tracked and cataloged, with varying degrees of success, in order to better understand their etiology and develop methods of prevention.
Zeyun Zhou, Kyle E. Hultgren
openalex +4 more sources
Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
Scientific ReportsTafamidis is the world's first and only oral drug approved to treat the rare disease transthyretin amyloid cardiomyopathy (ATTR-CM). Medicines are known to have different adverse reactions during the course of treatment.
Fan Wu, He Zhu, Yue Zhang
doaj +3 more sources